4//SEC Filing
SANDMAN PAUL W 4
Accession 0001181431-09-019625
CIK 0000882104other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 4:31 PM ET
Size
7.9 KB
Accession
0001181431-09-019625
Insider Transaction Report
Form 4
SANDMAN PAUL W
Director
Transactions
- Purchase
Common Stock
2009-04-08$7.38/sh+10,000$73,822→ 52,500 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $7.35 to $7.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001191251
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 4:31 PM ET
- Size
- 7.9 KB